Burnett Joseph
BURNETT JOSEPH, CEO, PRES, reported a transaction classified as exercise at ClearPoint Neuro, Inc. involving 12517.000000 shares for an estimated $0.00. Reported holdings after the transaction were 61887.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 02, 2026
- Filing date
- Sep 03, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CLPT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-382208 Stock Options (right to buy)
- Transaction date
- Sep 02, 2026 Filed Sep 03, 2026, 10:22 PM · 1d delay
- Shares
- 12,517 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 61,887 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
CEO and President
- F1
Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.
- F2
These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
- F3
The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and…
0 other transactions
0 recent txs